Overview
Gastroenterology has one denial pattern that outweighs all others: a colonoscopy that starts as a screening and becomes diagnostic when a polyp is found. Bill it wrong and either the patient gets an unexpected bill or the claim denies outright. Add anesthesia billing and infusion therapy, and the margin for error narrows further.
Why these claims get denied
The denial reasons we see most often in gastroenterology — and what our pre-billing checks are built to catch.
- Screening colonoscopy converted to diagnostic without modifier PT or 33
- Patient charged cost-sharing on a preventive service that should have none
- Surveillance interval billed before the payer's frequency limit allows
- Anesthesia units and base values miscalculated on endoscopic cases
- Biologic infusion drugs billed with incorrect units or wastage not reported
- Modifier 59 misuse on multiple endoscopic procedures in the same session
A real claim from this specialty
The kind of claim we see every week in gastroenterology, and the denial that usually follows it.
Sample claim · single date of serviceGastroenterology
45385 PTColonoscopy with snare polypectomy$742.00
45380 59Colonoscopy with biopsy$196.00
Z12.11Screening for colon neoplasm—
Denied — screening converted to diagnostic
How we resolved itModifier PT was missing after the polyp was removed. Added, refiled, and the patient's cost-sharing was corrected to $0.
What we do for your practice
- Screening-to-diagnostic conversion logic applied correctly on every case
- Modifier PT and 33 usage matched to each payer's specific requirement
- Frequency and surveillance interval tracking against payer coverage rules
- Infusion and biologic billing with accurate units, J-codes, and wastage reporting
- Anesthesia time and base unit verification on endoscopy cases
- Patient responsibility calculated correctly so preventive stays preventive
Codes and rules that matter here45378–45398 colonoscopy family, G0105/G0121 screening colonoscopy, 43235–43259 upper endoscopy, plus J-codes for biologics and 96360-family infusion administration.
Common questions
What happens when a screening colonoscopy becomes diagnostic?
When a polyp is found and removed, the procedure code changes but the preventive benefit should be preserved. Modifier PT (Medicare) or 33 (commercial) signals the conversion so the patient keeps their $0 cost-sharing. Missing it causes both a denial and an unexpected patient bill.
How are surveillance intervals tracked?
Payers apply frequency limits based on risk category — typically 10 years for average risk and shorter for high risk or post-polypectomy surveillance. Billing before the interval elapses denies as too frequent, so we track it per patient.
Do you handle infusion and biologic billing?
Yes. J-code units, administration codes, and drug wastage reporting all have to align. Unit errors on biologics are high-dollar and easy to miss on a busy schedule.